Blaine Davis, Chief Financial Officer at Cartesian Therapeutics, Inc. (RNAC), sold 10,591 shares at $6.82 ($72K) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Open-market sale of $72k RNAC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |